Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vasospasm, Intracranial | 1 | 2020 | 208 | 0.640 |
Why?
|
Heart Transplantation | 3 | 2023 | 3113 | 0.490 |
Why?
|
Cannabis | 1 | 2020 | 440 | 0.470 |
Why?
|
Cerebrovascular Disorders | 1 | 2020 | 1504 | 0.460 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1619 | 0.360 |
Why?
|
Neuromyelitis Optica | 2 | 2024 | 252 | 0.350 |
Why?
|
Stroke | 4 | 2023 | 9975 | 0.300 |
Why?
|
Hospital Mortality | 1 | 2020 | 5316 | 0.280 |
Why?
|
New York City | 3 | 2021 | 705 | 0.240 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2021 | 2200 | 0.210 |
Why?
|
Myasthenia Gravis | 1 | 2022 | 199 | 0.180 |
Why?
|
Incretins | 1 | 2021 | 88 | 0.180 |
Why?
|
Myositis | 1 | 2022 | 251 | 0.180 |
Why?
|
Natural Killer T-Cells | 1 | 2022 | 316 | 0.170 |
Why?
|
Leukocytosis | 1 | 2020 | 247 | 0.170 |
Why?
|
Shock | 1 | 2021 | 318 | 0.160 |
Why?
|
Brain Death | 1 | 2022 | 348 | 0.160 |
Why?
|
Acute Kidney Injury | 2 | 2022 | 1968 | 0.160 |
Why?
|
Immune System Diseases | 1 | 2021 | 261 | 0.160 |
Why?
|
Coated Materials, Biocompatible | 1 | 2020 | 318 | 0.160 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2022 | 339 | 0.160 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3134 | 0.160 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3241 | 0.150 |
Why?
|
Vasoconstriction | 1 | 2020 | 597 | 0.150 |
Why?
|
Graft Survival | 3 | 2023 | 3734 | 0.150 |
Why?
|
Age Factors | 4 | 2022 | 18355 | 0.150 |
Why?
|
Renal Insufficiency | 1 | 2023 | 805 | 0.140 |
Why?
|
Critical Pathways | 1 | 2020 | 476 | 0.140 |
Why?
|
Tissue Donors | 2 | 2022 | 2241 | 0.130 |
Why?
|
Down Syndrome | 1 | 2023 | 880 | 0.130 |
Why?
|
Myocarditis | 1 | 2022 | 768 | 0.130 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2022 | 980 | 0.120 |
Why?
|
Hemoglobins | 1 | 2020 | 1531 | 0.120 |
Why?
|
Syndrome | 1 | 2020 | 3249 | 0.120 |
Why?
|
Thromboembolism | 1 | 2020 | 987 | 0.120 |
Why?
|
Cardiovascular Agents | 1 | 2020 | 850 | 0.120 |
Why?
|
Drug-Eluting Stents | 1 | 2020 | 753 | 0.110 |
Why?
|
Retrospective Studies | 8 | 2024 | 77410 | 0.110 |
Why?
|
Hepatitis C, Chronic | 1 | 2021 | 1029 | 0.110 |
Why?
|
Pandemics | 4 | 2020 | 8385 | 0.110 |
Why?
|
Paclitaxel | 1 | 2020 | 1705 | 0.110 |
Why?
|
Heart Arrest | 1 | 2022 | 1470 | 0.110 |
Why?
|
Aquaporin 4 | 2 | 2024 | 153 | 0.110 |
Why?
|
Colitis | 1 | 2020 | 1170 | 0.110 |
Why?
|
Hepatitis C | 1 | 2021 | 1591 | 0.100 |
Why?
|
Risk Factors | 10 | 2023 | 72252 | 0.090 |
Why?
|
Aortic Valve Stenosis | 1 | 2023 | 1955 | 0.090 |
Why?
|
Prognosis | 5 | 2022 | 29052 | 0.090 |
Why?
|
Complement System Proteins | 2 | 2024 | 796 | 0.090 |
Why?
|
Patient Readmission | 1 | 2024 | 3117 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6539 | 0.090 |
Why?
|
Peripheral Arterial Disease | 1 | 2020 | 1188 | 0.090 |
Why?
|
Humans | 26 | 2024 | 743811 | 0.090 |
Why?
|
Ambulatory Care | 1 | 2020 | 2707 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 3047 | 0.080 |
Why?
|
Pneumonia | 1 | 2021 | 2133 | 0.080 |
Why?
|
Postoperative Complications | 2 | 2022 | 15281 | 0.080 |
Why?
|
Databases, Factual | 2 | 2021 | 7729 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3778 | 0.080 |
Why?
|
Registries | 2 | 2022 | 8090 | 0.080 |
Why?
|
Aged | 10 | 2022 | 163178 | 0.080 |
Why?
|
Incidence | 3 | 2021 | 20948 | 0.080 |
Why?
|
Brain Ischemia | 1 | 2022 | 3264 | 0.080 |
Why?
|
Kidney Transplantation | 1 | 2023 | 4251 | 0.080 |
Why?
|
Risk Assessment | 7 | 2023 | 23327 | 0.070 |
Why?
|
Japan | 2 | 2022 | 1360 | 0.070 |
Why?
|
Endovascular Procedures | 1 | 2020 | 1980 | 0.070 |
Why?
|
Sex Factors | 1 | 2020 | 10394 | 0.070 |
Why?
|
Dementia | 1 | 2020 | 2518 | 0.070 |
Why?
|
Comorbidity | 1 | 2020 | 10380 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12354 | 0.070 |
Why?
|
Aged, 80 and over | 5 | 2022 | 57744 | 0.060 |
Why?
|
Immunotherapy | 1 | 2021 | 4437 | 0.060 |
Why?
|
Autoantibodies | 2 | 2024 | 2037 | 0.060 |
Why?
|
United States Food and Drug Administration | 2 | 2022 | 1582 | 0.060 |
Why?
|
Middle Aged | 7 | 2022 | 213241 | 0.060 |
Why?
|
Female | 11 | 2023 | 380020 | 0.060 |
Why?
|
Male | 10 | 2022 | 349776 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2020 | 21733 | 0.050 |
Why?
|
United States | 4 | 2023 | 69859 | 0.050 |
Why?
|
Antigen-Antibody Complex | 1 | 2024 | 517 | 0.050 |
Why?
|
Receptors, Complement | 1 | 2022 | 264 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2020 | 6485 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10259 | 0.050 |
Why?
|
Biometry | 1 | 2023 | 558 | 0.050 |
Why?
|
Leukopenia | 1 | 2020 | 213 | 0.040 |
Why?
|
Adult | 4 | 2021 | 213889 | 0.040 |
Why?
|
Receptors, IgG | 1 | 2022 | 581 | 0.040 |
Why?
|
Coma | 1 | 2022 | 475 | 0.040 |
Why?
|
Femoral Artery | 1 | 2023 | 845 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 426 | 0.040 |
Why?
|
Treatment Outcome | 5 | 2023 | 63042 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2024 | 902 | 0.040 |
Why?
|
New York | 1 | 2020 | 885 | 0.040 |
Why?
|
Area Under Curve | 1 | 2022 | 1654 | 0.040 |
Why?
|
Thrombectomy | 1 | 2022 | 680 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2024 | 1836 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 11729 | 0.040 |
Why?
|
Logistic Models | 2 | 2022 | 13404 | 0.030 |
Why?
|
Intracranial Hemorrhages | 1 | 2022 | 855 | 0.030 |
Why?
|
Temperature | 1 | 2022 | 2202 | 0.030 |
Why?
|
Fetus | 1 | 2023 | 1880 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 1 | 2022 | 1263 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2023 | 2167 | 0.030 |
Why?
|
Fever | 1 | 2022 | 1616 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15142 | 0.030 |
Why?
|
Gestational Age | 1 | 2023 | 3488 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 9944 | 0.030 |
Why?
|
Hepacivirus | 1 | 2021 | 1378 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2024 | 3208 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2131 | 0.030 |
Why?
|
Prosthesis Design | 1 | 2020 | 2103 | 0.030 |
Why?
|
Aortic Valve | 1 | 2023 | 1920 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2022 | 2162 | 0.030 |
Why?
|
Forecasting | 1 | 2022 | 2950 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2022 | 2159 | 0.030 |
Why?
|
Inpatients | 1 | 2024 | 2515 | 0.030 |
Why?
|
Vascular Surgical Procedures | 1 | 2021 | 1476 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2024 | 4561 | 0.030 |
Why?
|
Neoplasms | 1 | 2020 | 21675 | 0.020 |
Why?
|
Acute Disease | 1 | 2021 | 7150 | 0.020 |
Why?
|
Risk | 1 | 2022 | 9677 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2021 | 2984 | 0.020 |
Why?
|
Cytokines | 1 | 2024 | 7324 | 0.020 |
Why?
|
Time Factors | 2 | 2021 | 40038 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2862 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9848 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 53250 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7185 | 0.020 |
Why?
|
Models, Statistical | 1 | 2022 | 5100 | 0.020 |
Why?
|
Research Design | 1 | 2022 | 5983 | 0.020 |
Why?
|
Disease Progression | 1 | 2021 | 13273 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2023 | 25609 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39001 | 0.010 |
Why?
|
Brain | 1 | 2023 | 26345 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 35409 | 0.010 |
Why?
|
Concepts
(136)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_